Together, these functional studies with nondegradable Skp2AA demonstrate that knockdown of RCC1 could suppress the growth of STS tumor in vivo by downregulating the Skp2 abundance to block the cell proliferation. The gene discussed is RCC1; the disease is telomere syndrome.